Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Mitochondrial dysfunction is implicated in neurodegenerative diseases, notably amyotrophic lateral sclerosis (ALS).
• Abnormalities include altered morphology, dynamics, enzyme activity, and increased reactive oxygen species in ALS.
• Genetic evidence links mitochondrial defects to the primary cause of motor neuron damage in ALS.

Purpose of the Study:

• To review the critical role of mitochondria in ALS pathogenesis.
• To highlight ALS-associated gene variants impacting mitochondrial function.
• To explore mitochondria as a therapeutic target for ALS.

Main Methods:

• Literature review focusing on mitochondrial dysfunction in ALS.
• Analysis of genetic studies identifying ALS-related mitochondrial gene variants.
• Synthesis of evidence linking mitochondrial pathways to motor neuron loss.

Main Results:

• Mitochondria are central to ALS pathology, contributing significantly to motor neuron degeneration.
• Specific gene variants (e.g., CHCHD10) directly implicate primary mitochondrial defects in ALS.
• Converging pathogenic pathways in ALS suggest a common endpoint of motor neuron loss.

Conclusions:

• Mitochondrial dysfunction is a primary driver in ALS pathogenesis.
• Targeting a single pathological process has yielded limited therapeutic success.
• Combined therapies addressing mitochondrial dysfunction represent a promising future direction for ALS treatment.